Alta Partners
Venture capitalJackson · Seed–Growth · 4 people tracked
Investment thesis
Alta Partners invests in healthcare companies leveraging technology and innovation to improve patient outcomes. The firm believes healthcare should prioritize patient interests and supports entrepreneurs building high-impact companies that integrate physicians, payers, and patients to challenge the status quo in the healthcare sector.
Source: firm website, verified Jul 21, 2026.
Team · 4 people
from the firm's websiteWhat they invest in
from 8 of 46 portfolio companiesBiotech ×4Healthtech ×4Medical Devices ×4Deep Tech ×2Digital Health ×2SaaS ×2AI & Machine Learning ×1B2B Marketplaces ×1
HQs:United States×4
Investments · 46 tracked
founders shown can be your intro pathB cell engraftment and immune cell therapeutics
Ark provides a customizable digital platform for venture capital and private equity firms to manage investor communications, performance reporting, and document sharing with their limited partners. The portal offers branded dashboards, secure data management, and streamlined quarterly reporting.
Enterprise SoftwareFintechSaaS
DispatchHealth delivers in-home medical care and house call services, offering patients an alternative to emergency rooms and urgent care facilities for acute medical conditions.
Digital HealthHealthtech
Dr. Mark Prather(Founder)Kevin Riddleberger(Founder)
Gene-edited pig kidney xenotransplants for clinical transplant trials
Free Market Health operates a care-driven marketplace platform for the specialty pharmacy ecosystem. The platform connects patients with specialty pharmacies and helps implement value-based care models for pharmacies, payers, and patients.
B2B MarketplacesHealthtechSaaSPittsburgh, US
Harbor Health is a healthcare provider and insurance company operating clinics across Texas that offers primary care, specialty care, and health coaching alongside integrated insurance coverage.
HealthtechInsurTechAustin, US
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
BiotechDeep TechMedical Devices
Mike Curtis, Ph.D.(President & Chief Executive Officer)
Developing in vivo CAR-T cell therapies for cancer treatment
Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells. The company targets the significant unmet need for remyelinating treatments that could repair damage caused by MS and potentially restore lost function.
BiotechDeep TechMedical Devices
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units. The company's products are used to support nutrition and reduce complications in extremely premature infants globally.
BiotechHealthtechMedical Devices
Clinical-stage biotechnology company focused on precision medicines
Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities. The company targets patients with unmet medical needs across these therapeutic areas.
AI & Machine LearningBiotechDigital HealthMedical Devices
Marianne De Backer(CEO)
Chronic hepatitis B virus therapeutics
Frequently asked questions
- What stage does Alta Partners invest at?
- Alta Partners invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Alta Partners focus on?
- Alta Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Alta Partners located?
- Alta Partners is headquartered in Jackson, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.